Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 2.14% |
| Q2 2025 | 21.36% |
| Q1 2025 | -20.07% |
| Q4 2024 | 1.84% |
| Q3 2024 | 4.89% |
| Q2 2024 | 12.79% |
| Q1 2024 | -8.42% |
| Q4 2023 | 2.13% |
| Q3 2023 | 6.48% |
| Q2 2023 | -0.13% |
| Q1 2023 | -7.39% |
| Q4 2022 | 16.29% |
| Q3 2022 | 2.76% |
| Q2 2022 | -3.64% |
| Q1 2022 | -40.12% |
| Q4 2021 | 43.41% |
| Q3 2021 | -32.81% |
| Q2 2021 | 103.21% |
| Q1 2021 | 4.37% |
| Q4 2020 | 5.62% |
| Q3 2020 | 17.52% |
| Q2 2020 | 6.77% |
| Q1 2020 | -1.89% |
| Q4 2019 | 6.87% |
| Q3 2019 | 10.51% |
| Q2 2019 | 14.95% |
| Q1 2019 | -28.80% |
| Q4 2018 | 15.89% |
| Q3 2018 | 3.45% |
| Q2 2018 | 6.39% |
| Q1 2018 | -4.48% |
| Q4 2017 | 5.45% |
| Q3 2017 | 2.08% |
| Q2 2017 | 11.46% |
| Q1 2017 | 7.51% |
| Q4 2016 | 0.55% |
| Q3 2016 | 0.62% |
| Q2 2016 | 0.98% |
| Q1 2016 | 9.36% |
| Q4 2015 | -3.46% |